Formulation of an antibody and use thereof
AssigneeTakeda GmbH
InventorsMarkus RAST, Wolfgang ISE, Gerhard BECKER, Peter SKUFCA, Henning GIESELER
Life of this patent
Estimating the term…
Loading patent…
AssigneeTakeda GmbH
InventorsMarkus RAST, Wolfgang ISE, Gerhard BECKER, Peter SKUFCA, Henning GIESELER
Estimating the term…
The present invention provides a method for preparation of a lyophilized formulation of an anti-CD 20 antibody as well as to a lyophilized formulation of an anti-CD 20 antibody, comprising an anti-CD 20 antibody and having a residual moisture content in the range of 1% to 10%. The present invention also relates to the reconstituted formulation obtained by the method described herein, the use of said antibody formulation as a medicament, the use of the lyophilized formulation for the preparation of a medicament and a method of treating a patient.
A method for providing a lyophilized formulation of an anti-CD 20 antibody, comprising the steps of:
A lyophilized formulation comprising an anti-CD 20 antibody wherein the lyophilized formulation has a residual moisture content in the range of 1% to 10%.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.